May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Eicosanoids as Mediators of Inflammation in Diabetic Retinopathy
Author Affiliations & Notes
  • R.A. Gubitosi–Klug
    Pediatrics, Rainbow Babies and Children's Hospital/CWRU, Cleveland, OH
  • T.S. Kern
    Medicine, Case Western Reserve University, Cleveland, OH
  • Footnotes
    Commercial Relationships  R.A. Gubitosi–Klug, None; T.S. Kern, None.
  • Footnotes
    Support  Endocrine Fellows Foundation
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 425. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.A. Gubitosi–Klug, T.S. Kern; Eicosanoids as Mediators of Inflammation in Diabetic Retinopathy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):425.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Inflammatory–like processes and capillary cell death play important roles in the pathogenesis of diabetic retinopathy. Metabolites of arachidonic acid via the cyclooxygenase and lipoxygenase pathways, collectively known as eicosanoids, are known mediators of inflammation. Investigation of the role of 12–lipoxygenase and its metabolite, 12–HETE, in the pathogenesis of diabetic retinopathy was performed. Methods: Streptozotocin–induced diabetic mice were analyzed for 1) 12–lipoxygenase protein expression by Western blot analysis, 2) 12–HETE generation by HPLC analysis, and 3) leukostasis by in vivo perfusion with concanavalin A. The selective 12–lipoxygenase inhibitor, baicalein, was administered to primary retinal endothelial cell cultures and to streptozotocin–induced diabetic mice. Results: 12–lipoxygenase expression is upregulated 2–fold in retinas from streptozotocin–induced diabetic mice compared to nondiabetic control mice. Similarly, 12–HETE production from diabetic retinas is increased (80pg/mg protein in diabetic retinas and undetectable in nondiabetic retinas). As a measure of the diabetes–induced inflammatory process in vivo, diabetic mice demonstrated an increased attraction of leukocytes to the vascular endothelium. Oral administration of baicalein to diabetic mice for 8 weeks normalized this leukocyte adherence. Primary cultures of retinal endothelial cells exposed to high glucose concentrations (25 mM) experience cell death that is preventable by incubation with baicalein. Conclusions:These experiments suggest that 12–lipoxygenase, through its role in retinal inflammation and retinal cell death, may participate in the pathogenesis of diabetic retinopathy.

Keywords: diabetic retinopathy • eicosanoids • inflammation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.